News
12 Health Care Stocks Moving In Thursday's After-Market Session
25 Apr 24
Movers
12 Health Care Stocks Moving In Friday's After-Market Session
5 Apr 24
Movers
Wedbush Assumes Gossamer Bio at Outperform, Announces Price Target of $4
5 Apr 24
News, Price Target, Initiation, Analyst Ratings
Piper Sandler Maintains Overweight on Gossamer Bio, Maintains $15 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
6 Mar 24
Analyst Ratings
Goldman Sachs Maintains Buy on Gossamer Bio, Lowers Price Target to $8
6 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
6 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Gossamer Bio Q4 EPS $(0.21), Inline; Cash, Cash Equivalents And Marketable Securities Of $296.4M Is Expected To Provide Cash Runway Into The First Half Of 2026
5 Mar 24
Earnings, News
On March 4, 2024, Gossamer Bio Received Letter Stating That It Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq
4 Mar 24
News
12 Health Care Stocks Moving In Tuesday's Intraday Session
20 Feb 24
Movers